AGMB

NASD AgomAb Therapeutics NV ADR

Nov 1, 2026 · 8:37 PM ET EOD Market Closed

$7.49 ↑ +0.00 (+0.00%) Trading Up from the previous close of $7.49, $0.47 below the day’s high of $7.96

YTD change: -48.87%
vs 20-day SMA: -13.73%
vs 200-day SMA: N/A

Price ranges

Previous day

$6.61 $7.96

open $7.00 close $7.49

+$0.49 (+7.00%)

Today

$6.61 $7.96

$7.49

Past week

$7.45 $9.33

from $9.26 now $7.49

-$1.77 (-19.11%)

Past month

$7.45 $9.65

from $8.65 now $7.49

-$1.16 (-13.41%)

This year

$6.61 $17.82

from $14.65 now $7.49

-$7.16 (-48.87%)

Price & Performance

-3.70 (-33.07%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor

The stock is 58.0% away from all-time highs of $17.82
AGMB is down 49% since the beginning of the year
AGMB is down 49% over the past 12 months
AGMB is down 13% over the past 1 month
3% of all AGMB investors are betting against AGMB

AGMB reads poor: the 12-month move is -48.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.687433

Earnings momentum -102.3% Quarterly EPS growth

Quarterly change -102.3%

Valuation

P/E ratio N/A

Enterprise value $37.3M

Beta 1.80

Balance sheet & scale

IncomeN/A

RevenueN/A

Cash$288.1M

Debt$1.3K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Professional, Scientific, and Technical Services

Industry Group Scientific Research and Development Services

Market cap $368.9M

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

Competitor comparison

Ticker	Company	Price	Change
AMGN	Amgen Inc.	$466.01	+1.15%
MRNA	Moderna, Inc.	$221.72	-0.47%
RVMD	Revolution Medicines, Inc.	$191.31	+0.55%
ROIV	Roivant Sciences Ltd.	$36.91	-1.63%
BNTX	BioNTech SE Sponsored ADR	$88.17	-1.08%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.